Merck & Co., Inc. (MRK) Tops Q4 EPS by 2c, Sales Miss Slightly

Merck & Co., Inc. (NYSE: MRK) reported Q4 EPS of $0.97, $0.02 better than the analyst estimate of $0.95. Revenue for the quarter came in at $12.29 billion versus the consensus estimate of $12.53 billion.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• CoStar Group acquires Zonda for $800M, adding new home data